Upload
red-strwberry
View
217
Download
0
Embed Size (px)
Citation preview
7/31/2019 Fibrocystic Changes
1/335
Fibrocystic changes
a)is the most common breast disorder in women
b)is due to abnormal response to ovarian hormones
c)is associated with in-situ carcinoma
d)has high risk of developing breast cancer
e)is also known as fibroadenoma
2.
Endo
7/31/2019 Fibrocystic Changes
2/335
metri
al
cance
7/31/2019 Fibrocystic Changes
3/335
r
isa)associ
7/31/2019 Fibrocystic Changes
4/335
atedwithuse
7/31/2019 Fibrocystic Changes
5/335
ofintrauteri
7/31/2019 Fibrocystic Changes
6/335
necontracep
7/31/2019 Fibrocystic Changes
7/335
tivedevice
7/31/2019 Fibrocystic Changes
8/335
b)associated
7/31/2019 Fibrocystic Changes
9/335
withexcess
7/31/2019 Fibrocystic Changes
10/335
estrogenc)ob
7/31/2019 Fibrocystic Changes
11/335
esityas arisk
7/31/2019 Fibrocystic Changes
12/335
factord)cle
7/31/2019 Fibrocystic Changes
13/335
arcellCA is
7/31/2019 Fibrocystic Changes
14/335
themostcom
7/31/2019 Fibrocystic Changes
15/335
mone)associa
7/31/2019 Fibrocystic Changes
16/335
tedwithHPV
7/31/2019 Fibrocystic Changes
17/335
infection
7/31/2019 Fibrocystic Changes
18/335
3.Inthearea
7/31/2019 Fibrocystic Changes
19/335
ofmolecular
7/31/2019 Fibrocystic Changes
20/335
pathologyand
7/31/2019 Fibrocystic Changes
21/335
moleculardiag
7/31/2019 Fibrocystic Changes
22/335
nosis,
7/31/2019 Fibrocystic Changes
23/335
a)Thedete
7/31/2019 Fibrocystic Changes
24/335
ctionofmon
7/31/2019 Fibrocystic Changes
25/335
oclonalityis
7/31/2019 Fibrocystic Changes
26/335
essentialin
7/31/2019 Fibrocystic Changes
27/335
diagnosing
7/31/2019 Fibrocystic Changes
28/335
biopsysam
7/31/2019 Fibrocystic Changes
29/335
plesof
7/31/2019 Fibrocystic Changes
30/335
breastcanc
7/31/2019 Fibrocystic Changes
31/335
er.b)Micros
7/31/2019 Fibrocystic Changes
32/335
omalinstability
7/31/2019 Fibrocystic Changes
33/335
arehelpful in
7/31/2019 Fibrocystic Changes
34/335
diagnosing
7/31/2019 Fibrocystic Changes
35/335
HNPCCc)Th
7/31/2019 Fibrocystic Changes
36/335
edetection
7/31/2019 Fibrocystic Changes
37/335
ofmonoclon
7/31/2019 Fibrocystic Changes
38/335
alityisesse
7/31/2019 Fibrocystic Changes
39/335
ntialindiag
7/31/2019 Fibrocystic Changes
40/335
nosingbiops
7/31/2019 Fibrocystic Changes
41/335
ysam
7/31/2019 Fibrocystic Changes
42/335
plesof
7/31/2019 Fibrocystic Changes
43/335
lymphomas
7/31/2019 Fibrocystic Changes
44/335
d)HER2-neu
7/31/2019 Fibrocystic Changes
45/335
genedetection
7/31/2019 Fibrocystic Changes
46/335
byFISHtest
7/31/2019 Fibrocystic Changes
47/335
isusedto
7/31/2019 Fibrocystic Changes
48/335
diagnoseinher
7/31/2019 Fibrocystic Changes
49/335
itedbreast
7/31/2019 Fibrocystic Changes
50/335
cancer
7/31/2019 Fibrocystic Changes
51/335
e)FAP iscaus
7/31/2019 Fibrocystic Changes
52/335
edbymuta
7/31/2019 Fibrocystic Changes
53/335
tionsinthe
7/31/2019 Fibrocystic Changes
54/335
mis-match
7/31/2019 Fibrocystic Changes
55/335
repair
7/31/2019 Fibrocystic Changes
56/335
genes.
7/31/2019 Fibrocystic Changes
57/335
4.Gran
7/31/2019 Fibrocystic Changes
58/335
ulomas
7/31/2019 Fibrocystic Changes
59/335
a)aremainly
7/31/2019 Fibrocystic Changes
60/335
composeof
7/31/2019 Fibrocystic Changes
61/335
macrophages,
7/31/2019 Fibrocystic Changes
62/335
epitheloidcells
7/31/2019 Fibrocystic Changes
63/335
andlymphocyt
7/31/2019 Fibrocystic Changes
64/335
esb)arealwa
7/31/2019 Fibrocystic Changes
65/335
yscaused
7/31/2019 Fibrocystic Changes
66/335
byinfections
7/31/2019 Fibrocystic Changes
67/335
c)aremediated
7/31/2019 Fibrocystic Changes
68/335
byCD4+T
7/31/2019 Fibrocystic Changes
69/335
lymphocytes
7/31/2019 Fibrocystic Changes
70/335
d)aremediated
7/31/2019 Fibrocystic Changes
71/335
byIL-2and
7/31/2019 Fibrocystic Changes
72/335
alphaIFN
7/31/2019 Fibrocystic Changes
73/335
e)alwayscont
7/31/2019 Fibrocystic Changes
74/335
ainareaof
7/31/2019 Fibrocystic Changes
75/335
central
7/31/2019 Fibrocystic Changes
76/335
necrosis
7/31/2019 Fibrocystic Changes
77/335
5.Thesequ
7/31/2019 Fibrocystic Changes
78/335
enceofmeta
7/31/2019 Fibrocystic Changes
79/335
plasia-dyspl
7/31/2019 Fibrocystic Changes
80/335
asia-neoplasia
7/31/2019 Fibrocystic Changes
81/335
occurs inthe
7/31/2019 Fibrocystic Changes
82/335
neogenesis of
7/31/2019 Fibrocystic Changes
83/335
a)squamous
7/31/2019 Fibrocystic Changes
84/335
cellcarcinom
7/31/2019 Fibrocystic Changes
85/335
abladder
7/31/2019 Fibrocystic Changes
86/335
b)carcinoid of
7/31/2019 Fibrocystic Changes
87/335
thesmall
7/31/2019 Fibrocystic Changes
88/335
intestine
7/31/2019 Fibrocystic Changes
89/335
c)adenocarcin
7/31/2019 Fibrocystic Changes
90/335
omaofthe
7/31/2019 Fibrocystic Changes
91/335
Barret'soesp
7/31/2019 Fibrocystic Changes
92/335
hagus
7/31/2019 Fibrocystic Changes
93/335
d)squamous
7/31/2019 Fibrocystic Changes
94/335
cellcarcinom
7/31/2019 Fibrocystic Changes
95/335
a ofthelungs
7/31/2019 Fibrocystic Changes
96/335
e)malignant
7/31/2019 Fibrocystic Changes
97/335
lymphoma
7/31/2019 Fibrocystic Changes
98/335
6. Inacute
7/31/2019 Fibrocystic Changes
99/335
inflammation
7/31/2019 Fibrocystic Changes
100/335
a)decreased
7/31/2019 Fibrocystic Changes
101/335
bloodflow
7/31/2019 Fibrocystic Changes
102/335
toaffected
7/31/2019 Fibrocystic Changes
103/335
partb)increas
7/31/2019 Fibrocystic Changes
104/335
edvascular
7/31/2019 Fibrocystic Changes
105/335
permeability to
7/31/2019 Fibrocystic Changes
106/335
proteins
7/31/2019 Fibrocystic Changes
107/335
c)isassociate
7/31/2019 Fibrocystic Changes
108/335
dwithlocal
7/31/2019 Fibrocystic Changes
109/335
5hydroxytr
7/31/2019 Fibrocystic Changes
110/335
ytamine
7/31/2019 Fibrocystic Changes
111/335
release
7/31/2019 Fibrocystic Changes
112/335
d)causedby
7/31/2019 Fibrocystic Changes
113/335
mechanical
7/31/2019 Fibrocystic Changes
114/335
trauma
7/31/2019 Fibrocystic Changes
115/335
e)amanifesta
7/31/2019 Fibrocystic Changes
116/335
tionofthe
7/31/2019 Fibrocystic Changes
117/335
ability ofnorm
7/31/2019 Fibrocystic Changes
118/335
altissues to
7/31/2019 Fibrocystic Changes
119/335
respondto
7/31/2019 Fibrocystic Changes
120/335
damage
7/31/2019 Fibrocystic Changes
121/335
7.Regarding
7/31/2019 Fibrocystic Changes
122/335
Osteoarthritis
7/31/2019 Fibrocystic Changes
123/335
a)cartilage
7/31/2019 Fibrocystic Changes
124/335
fibrillation
7/31/2019 Fibrocystic Changes
125/335
b)pannus
7/31/2019 Fibrocystic Changes
126/335
formation
7/31/2019 Fibrocystic Changes
127/335
c)eburnation
7/31/2019 Fibrocystic Changes
128/335
ofbone
7/31/2019 Fibrocystic Changes
129/335
d)herberde
7/31/2019 Fibrocystic Changes
130/335
n'snodes
7/31/2019 Fibrocystic Changes
131/335
e)osteophyte
7/31/2019 Fibrocystic Changes
132/335
formation
7/31/2019 Fibrocystic Changes
133/335
8.Macr
7/31/2019 Fibrocystic Changes
134/335
ophages
7/31/2019 Fibrocystic Changes
135/335
a)play arole
7/31/2019 Fibrocystic Changes
136/335
ingraft
7/31/2019 Fibrocystic Changes
137/335
rejection
7/31/2019 Fibrocystic Changes
138/335
b)areinvolved
7/31/2019 Fibrocystic Changes
139/335
inantigen
7/31/2019 Fibrocystic Changes
140/335
recognition
7/31/2019 Fibrocystic Changes
141/335
c)Havemem
7/31/2019 Fibrocystic Changes
142/335
branerece
7/31/2019 Fibrocystic Changes
143/335
ptorsforFc
7/31/2019 Fibrocystic Changes
144/335
fragmentof
7/31/2019 Fibrocystic Changes
145/335
antibodiesd)Is
7/31/2019 Fibrocystic Changes
146/335
involvedin
7/31/2019 Fibrocystic Changes
147/335
type4hype
7/31/2019 Fibrocystic Changes
148/335
rsensitivity
7/31/2019 Fibrocystic Changes
149/335
e)Haveno
7/31/2019 Fibrocystic Changes
150/335
phagocytic
7/31/2019 Fibrocystic Changes
151/335
properties
7/31/2019 Fibrocystic Changes
152/335
9.Lowgrad
7/31/2019 Fibrocystic Changes
153/335
elymp
7/31/2019 Fibrocystic Changes
154/335
homas:
7/31/2019 Fibrocystic Changes
155/335
a)Incurable
7/31/2019 Fibrocystic Changes
156/335
b)monoclonal
7/31/2019 Fibrocystic Changes
157/335
proliferation of
7/31/2019 Fibrocystic Changes
158/335
largelymp
7/31/2019 Fibrocystic Changes
159/335
hoidcells
7/31/2019 Fibrocystic Changes
160/335
c)clinically
7/31/2019 Fibrocystic Changes
161/335
aggressive
7/31/2019 Fibrocystic Changes
162/335
10.11.Whic
7/31/2019 Fibrocystic Changes
163/335
h ofthefollo
7/31/2019 Fibrocystic Changes
164/335
winghelpsin
7/31/2019 Fibrocystic Changes
165/335
thegrading of
7/31/2019 Fibrocystic Changes
166/335
atumor?
7/31/2019 Fibrocystic Changes
167/335
a)thepresence
7/31/2019 Fibrocystic Changes
168/335
orabsence
7/31/2019 Fibrocystic Changes
169/335
ofmetastase
7/31/2019 Fibrocystic Changes
170/335
s inthelymp
7/31/2019 Fibrocystic Changes
171/335
hnode
7/31/2019 Fibrocystic Changes
172/335
b)thedegree of
7/31/2019 Fibrocystic Changes
173/335
differentiation
7/31/2019 Fibrocystic Changes
174/335
c)thepresence
7/31/2019 Fibrocystic Changes
175/335
oftumor
7/31/2019 Fibrocystic Changes
176/335
necrosis
7/31/2019 Fibrocystic Changes
177/335
d)mitotic
7/31/2019 Fibrocystic Changes
178/335
activity
7/31/2019 Fibrocystic Changes
179/335
e)thepresence
7/31/2019 Fibrocystic Changes
180/335
ofcellsin
7/31/2019 Fibrocystic Changes
181/335
thevascular
7/31/2019 Fibrocystic Changes
182/335
spaces
7/31/2019 Fibrocystic Changes
183/335
12.Successfu
7/31/2019 Fibrocystic Changes
184/335
lhealing of
7/31/2019 Fibrocystic Changes
185/335
longbones
7/31/2019 Fibrocystic Changes
186/335
dependsupon
7/31/2019 Fibrocystic Changes
187/335
:a)appositi
7/31/2019 Fibrocystic Changes
188/335
on ofthefrag
7/31/2019 Fibrocystic Changes
189/335
7/31/2019 Fibrocystic Changes
190/335
rgicalremoval of
7/31/2019 Fibrocystic Changes
191/335
thehematom
7/31/2019 Fibrocystic Changes
192/335
ac)Free
7/31/2019 Fibrocystic Changes
193/335
mobility ofthe
7/31/2019 Fibrocystic Changes
194/335
limbd)The
7/31/2019 Fibrocystic Changes
195/335
absenceof
7/31/2019 Fibrocystic Changes
196/335
infectione)Ele
7/31/2019 Fibrocystic Changes
197/335
vation of
7/31/2019 Fibrocystic Changes
198/335
thelimb
7/31/2019 Fibrocystic Changes
199/335
13.Small cell
7/31/2019 Fibrocystic Changes
200/335
carcinoma of
7/31/2019 Fibrocystic Changes
201/335
thelungis:
7/31/2019 Fibrocystic Changes
202/335
a.Isnotasso
7/31/2019 Fibrocystic Changes
203/335
ciatedwith
7/31/2019 Fibrocystic Changes
204/335
cigarettesmok
7/31/2019 Fibrocystic Changes
205/335
ing.b.Isusual
7/31/2019 Fibrocystic Changes
206/335
lyfound in
7/31/2019 Fibrocystic Changes
207/335
theperiphery
7/31/2019 Fibrocystic Changes
208/335
ofthelung.
7/31/2019 Fibrocystic Changes
209/335
c.Ismorecom
7/31/2019 Fibrocystic Changes
210/335
moninwom
7/31/2019 Fibrocystic Changes
211/335
enthanmen.
7/31/2019 Fibrocystic Changes
212/335
d.Oftenprod
7/31/2019 Fibrocystic Changes
213/335
ucesectopic
7/31/2019 Fibrocystic Changes
214/335
hormonese.Ha
7/31/2019 Fibrocystic Changes
215/335
s apoorprog
7/31/2019 Fibrocystic Changes
216/335
7/31/2019 Fibrocystic Changes
217/335
14.Adultrespi
7/31/2019 Fibrocystic Changes
218/335
ratorydistr
7/31/2019 Fibrocystic Changes
219/335
esssynd
7/31/2019 Fibrocystic Changes
220/335
rome:
7/31/2019 Fibrocystic Changes
221/335
a)pulmonary
7/31/2019 Fibrocystic Changes
222/335
edema isa
7/31/2019 Fibrocystic Changes
223/335
feature
7/31/2019 Fibrocystic Changes
224/335
b)hyalinemem
7/31/2019 Fibrocystic Changes
225/335
brane ispres
7/31/2019 Fibrocystic Changes
226/335
entin
7/31/2019 Fibrocystic Changes
227/335
alveoli
7/31/2019 Fibrocystic Changes
228/335
c)has ahigh
7/31/2019 Fibrocystic Changes
229/335
mortality
7/31/2019 Fibrocystic Changes
230/335
d)associated
7/31/2019 Fibrocystic Changes
231/335
7/31/2019 Fibrocystic Changes
232/335
pancreatitis
7/31/2019 Fibrocystic Changes
233/335
e)canoccu
7/31/2019 Fibrocystic Changes
234/335
rfollowing
7/31/2019 Fibrocystic Changes
235/335
diffusealveo
7/31/2019 Fibrocystic Changes
236/335
larinjury15.
7/31/2019 Fibrocystic Changes
237/335
16.Fallin
7/31/2019 Fibrocystic Changes
238/335
blood pHfrom
7/31/2019 Fibrocystic Changes
239/335
7.40to7.10
7/31/2019 Fibrocystic Changes
240/335
a)represents
7/31/2019 Fibrocystic Changes
241/335
anapproxim
7/31/2019 Fibrocystic Changes
242/335
atedoubling
7/31/2019 Fibrocystic Changes
243/335
ofH+conc
7/31/2019 Fibrocystic Changes
244/335
entrationb)ch
7/31/2019 Fibrocystic Changes
245/335
aracteristically
7/31/2019 Fibrocystic Changes
246/335
causedby
7/31/2019 Fibrocystic Changes
247/335
persistentvomit
7/31/2019 Fibrocystic Changes
248/335
ingc)charact
7/31/2019 Fibrocystic Changes
249/335
eristicallycaus
7/31/2019 Fibrocystic Changes
250/335
edbyhype
7/31/2019 Fibrocystic Changes
251/335
rventilationd)c
7/31/2019 Fibrocystic Changes
252/335
anbeacco
7/31/2019 Fibrocystic Changes
253/335
mpaniedby
7/31/2019 Fibrocystic Changes
254/335
elevatedseru
7/31/2019 Fibrocystic Changes
255/335
mpota
7/31/2019 Fibrocystic Changes
256/335
ssium
7/31/2019 Fibrocystic Changes
257/335
e)isincompat
7/31/2019 Fibrocystic Changes
258/335
iblewithlife
7/31/2019 Fibrocystic Changes
259/335
17.Whatof
7/31/2019 Fibrocystic Changes
260/335
thefollowing
7/31/2019 Fibrocystic Changes
261/335
causeseleva
7/31/2019 Fibrocystic Changes
262/335
tedtotalCSF
7/31/2019 Fibrocystic Changes
263/335
protein:
7/31/2019 Fibrocystic Changes
264/335
a)CNS
7/31/2019 Fibrocystic Changes
265/335
tumour
7/31/2019 Fibrocystic Changes
266/335
b)CVA
7/31/2019 Fibrocystic Changes
267/335
c)Epilepsy
7/31/2019 Fibrocystic Changes
268/335
d)Viral
7/31/2019 Fibrocystic Changes
269/335
meningitis
7/31/2019 Fibrocystic Changes
270/335
e)CNS
7/31/2019 Fibrocystic Changes
271/335
trauma
7/31/2019 Fibrocystic Changes
272/335
18. HPylori
7/31/2019 Fibrocystic Changes
273/335
a)associated
7/31/2019 Fibrocystic Changes
274/335
withgastric
7/31/2019 Fibrocystic Changes
275/335
carcinoma
7/31/2019 Fibrocystic Changes
276/335
andlymphom
7/31/2019 Fibrocystic Changes
277/335
ab)causes
7/31/2019 Fibrocystic Changes
278/335
achronic
7/31/2019 Fibrocystic Changes
279/335
lymphoid
7/31/2019 Fibrocystic Changes
280/335
infiltration
7/31/2019 Fibrocystic Changes
281/335
c)isaurea
-prod
7/31/2019 Fibrocystic Changes
282/335
ucingorganism
7/31/2019 Fibrocystic Changes
283/335
d)isusually
7/31/2019 Fibrocystic Changes
284/335
found inarea
7/31/2019 Fibrocystic Changes
285/335
s ofintestinal
7/31/2019 Fibrocystic Changes
286/335
metaplasia
7/31/2019 Fibrocystic Changes
287/335
e)causesa
7/31/2019 Fibrocystic Changes
288/335
chronicgastr
7/31/2019 Fibrocystic Changes
289/335
itisbyinvad
7/31/2019 Fibrocystic Changes
290/335
ingthemuc
7/31/2019 Fibrocystic Changes
291/335
osalepithelium
7/31/2019 Fibrocystic Changes
292/335
19.Pseudom
7/31/2019 Fibrocystic Changes
293/335
embranous
7/31/2019 Fibrocystic Changes
294/335
Colitis
7/31/2019 Fibrocystic Changes
295/335
a)causedby
7/31/2019 Fibrocystic Changes
296/335
clostridiumdiffici
7/31/2019 Fibrocystic Changes
297/335
letoxin
7/31/2019 Fibrocystic Changes
298/335
b)ispresent
7/31/2019 Fibrocystic Changes
299/335
inimmunos
7/31/2019 Fibrocystic Changes
300/335
uppressed
7/31/2019 Fibrocystic Changes
301/335
individualsc)toxi
7/31/2019 Fibrocystic Changes
302/335
nmediated
7/31/2019 Fibrocystic Changes
303/335
injurycauses
7/31/2019 Fibrocystic Changes
304/335
epithelialshed
7/31/2019 Fibrocystic Changes
305/335
dingandnecr
7/31/2019 Fibrocystic Changes
306/335
osisd)pseudo
7/31/2019 Fibrocystic Changes
307/335
membranes
7/31/2019 Fibrocystic Changes
308/335
presentby
7/31/2019 Fibrocystic Changes
309/335
desloughing of
7/31/2019 Fibrocystic Changes
310/335
epitheliume)as
7/31/2019 Fibrocystic Changes
311/335
sociatedwith
7/31/2019 Fibrocystic Changes
312/335
antibioticuse
7/31/2019 Fibrocystic Changes
313/335
20.Concernin
7/31/2019 Fibrocystic Changes
314/335
gSLEa)cir
7/31/2019 Fibrocystic Changes
315/335
culatingimm
7/31/2019 Fibrocystic Changes
316/335
unecomplexe
7/31/2019 Fibrocystic Changes
317/335
sresponsib
7/31/2019 Fibrocystic Changes
318/335
le forglomerulo
7/31/2019 Fibrocystic Changes
319/335
nephritisb)ab
7/31/2019 Fibrocystic Changes
320/335
soluteincre
7/31/2019 Fibrocystic Changes
321/335
asein Tsupp
7/31/2019 Fibrocystic Changes
322/335
ressorcells
7/31/2019 Fibrocystic Changes
323/335
c)renalbiops
7/31/2019 Fibrocystic Changes
324/335
yseldom
7/31/2019 Fibrocystic Changes
325/335
requiredfor
7/31/2019 Fibrocystic Changes
326/335
directingthera
7/31/2019 Fibrocystic Changes
327/335
pyd)renal
7/31/2019 Fibrocystic Changes
328/335
biopsyinclu
7/31/2019 Fibrocystic Changes
329/335
desactive
7/31/2019 Fibrocystic Changes
330/335
diffuseprolif
7/31/2019 Fibrocystic Changes
331/335
eratingglom
7/31/2019 Fibrocystic Changes
332/335
erulonephritis
7/31/2019 Fibrocystic Changes
333/335
e)ITPcan
7/31/2019 Fibrocystic Changes
334/335
beinitialmani
7/31/2019 Fibrocystic Changes
335/335
festation